Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release
- 1 January 1977
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 74 (2), 630-636
- https://doi.org/10.1016/0006-291x(77)90349-7
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Prevention of Human Diabetic Ketoacidosis by SomatostatinNew England Journal of Medicine, 1975
- STUDIES ON THE MECHANISM OF SOMATOSTATIN ACTION ON INSULIN RELEASE IN MANActa Endocrinologica, 1975
- STUDIES ON THE INHIBITORY EFFECT OF SOMATOSTATIN ON GLUCOSE INDUCED INSULIN RELEASE IN THE ISOLATED PERFUSED RAT PANCREASActa Endocrinologica, 1975
- Inhibition by Somatostatin of Glucagon and Insulin Release from the Perfused Rat Pancreas in Response to Arginine, Isoproterenol and Theophylline: Evidence for a Preferential Effect on Glucagon SecretionEndocrinology, 1975
- Effects of Somatostatin on Plasma Glucose and Glucagon Levels in Human Diabetes MellitusNew England Journal of Medicine, 1974
- Somatostatin: Hypothalamic Inhibitor of the Endocrine PancreasScience, 1974
- Effect of Somatostatin in Patients with AcromegalyNew England Journal of Medicine, 1974
- EFFECTS OF GROWTH-HORMONE RELEASE-INHIBITING HORMONE ON CIRCULATING GLUCAGON, INSULIN, AND GROWTH HORMONE IN NORMAL, DIABETIC, ACROMEGALIC, AND HYPOPITUITARY PATIENTSThe Lancet, 1974
- Growth Hormone Release Inhibiting Hormone in AcromegalyBMJ, 1974
- INHIBITION OF INSULIN SECRETION BY SOMATOSTATINThe Lancet, 1973